Forget Ocugen! Here’s a COVID Stock That Could Make You Richer Quicker

It’s taken the S&P 500 index 25 years to rise more than 500%. Ocugen (NASDAQ: OCGN) just did it in two weeks. Many investors have jumped aboard the Ocugen bandwagon after the drugmaker finalized a deal with Bharat Biotech to co-develop COVID-19 vaccine Covaxin for the U.S. maRead MoreMarketsMarkets Feed